Natasha Hernday

EVP, Corporate Development at Seattle Genetics

Natasha Hernday is the EVP of Corporate Development at Seattle Genetics. Natasha has over 16 years of experience in corporate development, including mergers and acquisitions, out-licensing, product valuation and financial analysis, and supporting licensing. Natasha also has experience in molecular and mammalian cell biology and research project management. Prior to their current position, they were the Vice President of Corporate Development at Seattle Genetics from January 2011 to September 2017.

Natasha Hernday has an MBA with an Emphasis in Corporate Finance and Marketing from Pepperdine Graziadio Business School, as well as a BA in Biology from UC Santa Barbara.

Natasha Hernday works with Tuomo Pätsi - Executive Vice President, Commercial International, Charles Romp - Executive Vice President, Commercial, and Vaughn B. Himes - Chief Technical Officer. Natasha Hernday reports to Clay B. Siegall, Chairman, President & CEO .

Links

Previous companies

Amgen logo
PDL BioPharma logo

Timeline

  • EVP, Corporate Development

    Current role

View in org chart